These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8188531)

  • 1. Augmented systemic immunity in mice implanted with tumor necrosis factor-alpha gene-transduced Meth-A-cells.
    Fujii S; Liu Y; Neda H; Itoh Y; Koshita Y; Takahashi M; Watanabe N; Kohgo Y; Niitsu Y
    Jpn J Cancer Res; 1994 Mar; 85(3):315-24. PubMed ID: 8188531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of TNF-alpha gene-transduced tumor cells in treatment of established in vivo tumor.
    Koshita Y; Lu Y; Fujii S; Neda H; Matsuyama T; Satoh Y; Itoh Y; Takahashi M; Kato J; Sakamaki S
    Int J Cancer; 1995 Sep; 63(1):130-5. PubMed ID: 7558441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic suppressive effect of double transfection of tumor necrosis factor-alpha and interleukin 12 genes on tumorigenicity of Meth-A cells.
    Fujiwara H; Yamauchi N; Sato Y; Sasaki K; Takahashi M; Okamoto T; Sato T; Iyama S; Koshita Y; Hirayama M; Yamagishi H; Niitsu Y
    Jpn J Cancer Res; 2000 Dec; 91(12):1296-302. PubMed ID: 11123429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration of rIL-12 synergistically enhances the therapeutic effect of a TNF gene-transduced cancer vaccine.
    Taniguchi F; Yamagishi H; Fujiwara H; Ueda Y; Fuji N; Yoshimura T; Oka T
    Gene Ther; 1998 Dec; 5(12):1677-84. PubMed ID: 10023447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in cellular composition induced by neocarzinostatin pretreatment in Meth A-bearing mice and the responsible antitumor effector cells.
    Masuda E; Shishido T; Fujimoto R; Maeda H
    Immunopharmacology; 1997 Aug; 37(1):105-16. PubMed ID: 9285249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
    Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
    Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule.
    Lu Y; Yamauchi N; Koshita Y; Fujiwara H; Sato Y; Fujii S; Takahashi M; Sato T; Kato J; Yamagishi H; Niitsu Y
    Gene Ther; 2001 Apr; 8(7):499-507. PubMed ID: 11319616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Krestin (PSK) on the induction of IL-2 activated killer cells.
    Sakamaki S; Kohgo Y; Nojiri S; Kanisawa Y; Ito Y; Takahashi M; Ueno Y; Hirayama Y; Niitsu Y
    Jpn J Clin Oncol; 1992 Apr; 22(2):79-83. PubMed ID: 1619782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.
    Cretney E; Takeda K; Yagita H; Glaccum M; Peschon JJ; Smyth MJ
    J Immunol; 2002 Feb; 168(3):1356-61. PubMed ID: 11801676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
    Fuyama S; Komatsu H; Arai S
    Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of astaxanthin and its mode of action.
    Jyonouchi H; Sun S; Iijima K; Gross MD
    Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
    Begovic M; Herberman R; Gorelik E
    Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of a new interleukin-2 slow delivery system on methylcholanthrene-induced fibrosarcoma in mice.
    Fujiwara T; Sakagami K; Orita K
    J Cancer Res Clin Oncol; 1990; 116(2):141-8. PubMed ID: 2324156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of TGF-beta1 in human gliomas by retroviral gene transfection enhances susceptibility to LAK cells.
    Yamanaka R; Tanaka R; Yoshida S; Saitoh T; Fujita K; Naganuma H
    J Neurooncol; 1999 May; 43(1):27-34. PubMed ID: 10448868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of the generation of cytotoxic T lymphocytes against syngeneic tumor cells by recombinant human tumor necrosis factor.
    Nakano K; Okugawa K; Furuichi H; Matsui Y; Sohmura Y
    Cell Immunol; 1989 Apr; 120(1):154-64. PubMed ID: 2649256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype of cytotoxic effector cells infiltrating a transplanted, chemically induced rat sarcoma.
    Ferry BL; Flannery GR; Robins RA; Lawry J; Baldwin RW
    Immunology; 1984 Oct; 53(2):243-50. PubMed ID: 6490084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked reduction of subcutaneous tumor growth by intraperitoneal administration of recombinant human interleukin 2 with a cell accumulator, proteose-peptone, in mice.
    Tanida S; Uchida H; Taniguchi K; Nomoto K
    Cancer Res; 1989 Jan; 49(2):284-8. PubMed ID: 2783379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.